These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 10923237)

  • 1. Cholelithiasis in a newborn following treatment with the somatostatin analogue octreotide.
    Radetti G; Gentili L; Paganini C; Messner H
    Eur J Pediatr; 2000 Jul; 159(7):550. PubMed ID: 10923237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tolerance to somatostatin analogue in a preterm infant with islet cell dysregulation syndrome.
    Hawdon JM; Ward Platt MP; Lamb WH; Aynsley-Green A
    Arch Dis Child; 1991 Mar; 66(3):341-3. PubMed ID: 2025013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical use of the long acting somatostatin analogue octreotide in pediatrics.
    Tauber MT; Harris AG; Rochiccioli P
    Eur J Pediatr; 1994 May; 153(5):304-10. PubMed ID: 8033916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective examination of octreotide-induced gall-bladder changes in acromegaly.
    Eastman RC; Arakaki RF; Shawker T; Schock R; Roach P; Comi RJ; Gorden P
    Clin Endocrinol (Oxf); 1992 Mar; 36(3):265-9. PubMed ID: 1563079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seizure due to somatostatin analog discontinuation in a case diagnosed as congenital hyperinsulinism novel mutation.
    Baş VN; Ozkan M; Zenciroğlu A; Cavuşoğlu YH; Cetinkaya S; Aycan Z
    J Pediatr Endocrinol Metab; 2012; 25(5-6):553-5. PubMed ID: 22876555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-acting somatostatin analog in refractory neonatal hypoglycemia: follow-up information.
    Jackson JA; Hahn HB; Oltorf CE
    J Pediatr; 1988 Dec; 113(6):1118. PubMed ID: 3142985
    [No Abstract]   [Full Text] [Related]  

  • 7. Successful management of congenital chylous ascites in a premature infant using somatostatin analogue.
    Huang Y; Zhuang S; Li Y; Liu M; Chen H; Du M
    Indian J Pediatr; 2011 Mar; 78(3):345-7. PubMed ID: 20953848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic treatment with a long-acting somatostatin analogue in a patient with intestinal carcinoid tumor: occurrence of cholelithiasis.
    Roti E; Minelli R; Gardini E; Salvi M; Bianconi L; Balducci L; Manfredi A; Braverman LE
    J Endocrinol Invest; 1990 Jan; 13(1):69-72. PubMed ID: 2319110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in glucose tolerance and development of gall stones during high dose treatment with octreotide for acromegaly.
    McKnight JA; McCance DR; Crothers JG; Atkinson AB
    BMJ; 1989 Sep; 299(6699):604-5. PubMed ID: 2508821
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effects of biliary lithogenesis in acromegalic patients with long-term octreotide (SMS 201-995) treatment].
    Buscail LE; Puel-Bousquet C; Harris AG; Tauber JP; Escourrou JR; Delvaux MM; Vaysse NM; Bayard F; Ribet A
    Gastroenterol Clin Biol; 1991; 15(11):800-4. PubMed ID: 1769469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late Presentation of Fulminant Necrotizing Enterocolitis in a Child with Hyperinsulinism on Octreotide Therapy.
    Hawkes CP; Adzick NS; Palladino AA; De León DD
    Horm Res Paediatr; 2016; 86(2):131-136. PubMed ID: 26867223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prospective study of functional changes in the gallbladder and formation of gallstones induced by long-term treatment of somatostatin analogue SMS201-995 in patients of active acromegaly].
    Zhu XF; Shi YF; Zhang JX
    Zhonghua Nei Ke Za Zhi; 1991 Jul; 30(7):405-8, 455. PubMed ID: 1752152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatostatin analogue in short term management of hyperinsulinism.
    Kirk JM; Di Silvio L; Hindmarsh PC; Brook CG
    Arch Dis Child; 1988 Dec; 63(12):1493-4. PubMed ID: 3232999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective study of the long-term effects of somatostatin analog (octreotide) on gallbladder function and gallstone formation in Chinese acromegalic patients.
    Shi YF; Zhu XF; Harris AG; Zhang JX; Dai Q
    J Clin Endocrinol Metab; 1993 Jan; 76(1):32-7. PubMed ID: 8421099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Linear growth during long-term treatment with somatostatin analog (SMS 201-995) for persistent hyperinsulinemic hypoglycemia of infancy.
    DeClue TJ; Malone JI; Bercu BB
    J Pediatr; 1990 May; 116(5):747-50. PubMed ID: 2184212
    [No Abstract]   [Full Text] [Related]  

  • 16. Normal growth after administration of octreotide: report on a case of persistent hyperinsulinemic hypoglycemia of infancy treated by continuous subcutaneous injection of octreotide.
    Kuno T; Fujita I; Ohta M; Kanemitsu H; Miyazaki S; Miyamoto S
    Endocr J; 1999 Mar; 46 Suppl():S47-9. PubMed ID: 12054118
    [No Abstract]   [Full Text] [Related]  

  • 17. Incidence and morbidity of cholelithiasis in patients receiving chronic octreotide for metastatic carcinoid and malignant islet cell tumors.
    Trendle MC; Moertel CG; Kvols LK
    Cancer; 1997 Feb; 79(4):830-4. PubMed ID: 9024721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis in an infant treated with octreotide for congenital hyperinsulinism.
    Koren I; Riskin A; Barthlen W; Gillis D
    J Pediatr Endocrinol Metab; 2013; 26(1-2):183-5. PubMed ID: 23327817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Octreotide as therapeutic option for congenital idiopathic chylothorax: a case series.
    Shah D; Sinn JK
    Acta Paediatr; 2012 Apr; 101(4):e151-5. PubMed ID: 22092874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complications of long-acting somatostatin analogue therapy.
    Jackson JA
    Am J Med; 1989 Apr; 86(4):512-3. PubMed ID: 2929652
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.